Extrait

Background and study aims Bowel cancer is the second most common cause of cancer death in the UK. Early diagnosis improves survival and in light of this the NHS established the Bowel Cancer Screening Programme (BCSP). This Programme offers screening using a stool testing kit (the faecal occult blood test) to 60-74 year olds. Data from 2012 shows that only 53% of those offered screening take it up and that this varies from more than 60% in the most socially advantaged areas of the country to less than 35% in the most disadvantaged areas. This study aims to increase uptake in the BCSP, and to reduce differences in uptake between the most and least socially advantaged groups, whilst ensuring that uptake does not decline in any socioeconomic (SE) group. The study will test whether or not receiving an endorsement from your GP at the same time that you receive a kit as part of the BCSP is likely to increase uptake and/or reduce SE inequalities. Who can participate? Individuals who are routinely invited for screening in the BCSP (age 60-74 with a registered GP). What does the study involve? Participants will be randomly allocated either to receive an invitation letter with a GP endorsement or the standard letter currently sent out by the BCSP without an endorsement. What are the possible benefits and risks of participating? No benefits or risks are expected as the study is carried out within the participant’s standard care pathway as part of the Bowel Cancer Screening Programme – the usual benefits and risks of participating in the Bowel Cancer Screening Programme would still apply. Where is the study run from? Imperial College London (UK) When is the study starting and how long is it expected to run for? March to December 2015 Who is funding the study? University College London (UK) Who is the main contact? Dr Laura Turner

Critère d'inclusion

• Colorectal cancer/bowel cancer

Liens

• ictrp
• isrctn